Laboratory Corporation of America Holdings
Laboratory Corporation of America Holdings was paid $175K by Medicaid between Jan 2018 and Aug 2024, across 17 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 73% of everything it billed.
MC KEES ROCKS, PA 15136
Next to other Clinical Medical Laboratory providers in Pennsylvania
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 661 | $2K | |
| 2019 | 922 | $119.00 | |
| 2020 | 326 | $3K | |
| 2021 | 1,838 | $71K | |
| 2022 | 2,013 | $99K | |
| 2023 | 486 | $507.72 | |
| 2024incomplete | 80 | $32.43 |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 73% | 2,101 | 1,996 | $128K |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 24% | 53 | 53 | $42K |
| 87070 | 1.3% | 500 | 438 | $2K | |
| 86769 | <1% | 12 | 12 | $840.08 | |
| 80053 | Comprehensive metabolic panel | <1% | 1,179 | 907 | $678.32 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,216 | 935 | $595.81 |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 507 | 507 | $548.51 |
| 87081 | <1% | 25 | 25 | $74.24 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 352 | 270 | $67.50 |
| 80061 | Lipid panel | <1% | 37 | 37 | $35.84 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 48 | 48 | $31.47 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 24 | 24 | $15.57 |
5 more codes
| 85610 | <1% | 19 | $6.86 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 0% | 38 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 61 | $0.00 |
| 80197 | 0% | 25 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 129 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.